Alto Neuroscience, Inc. (ANRO)
24.00
-0.03
(-0.12%)
USD |
NYSE |
Oct 09, 09:53
Alto Neuroscience Price to Book Value : 3.841 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 3.846 |
| October 07, 2026 | 3.765 |
| October 06, 2026 | 3.792 |
| October 05, 2026 | 3.843 |
| October 02, 2026 | 3.970 |
| October 01, 2026 | 4.051 |
| September 30, 2026 | 4.086 |
| September 29, 2026 | 4.254 |
| September 28, 2026 | 4.267 |
| September 25, 2026 | 4.240 |
| September 24, 2026 | 4.350 |
| September 23, 2026 | 4.402 |
| September 22, 2026 | 4.927 |
| September 21, 2026 | 4.903 |
| September 18, 2026 | 4.845 |
| September 17, 2026 | 4.959 |
| September 16, 2026 | 4.802 |
| September 15, 2026 | 4.842 |
| September 14, 2026 | 5.071 |
| September 11, 2026 | 5.122 |
| September 10, 2026 | 5.071 |
| September 09, 2026 | 5.453 |
| September 08, 2026 | 5.732 |
| September 04, 2026 | 5.690 |
| September 03, 2026 | 5.826 |
| Date | Value |
|---|---|
| September 02, 2026 | 5.865 |
| September 01, 2026 | 5.634 |
| August 31, 2026 | 5.663 |
| August 28, 2026 | 5.623 |
| August 27, 2026 | 5.810 |
| August 26, 2026 | 5.847 |
| August 25, 2026 | 5.812 |
| August 24, 2026 | 5.802 |
| August 21, 2026 | 5.487 |
| August 20, 2026 | 5.482 |
| August 19, 2026 | 5.585 |
| August 18, 2026 | 5.463 |
| August 17, 2026 | 5.378 |
| August 14, 2026 | 5.144 |
| August 13, 2026 | 5.170 |
| August 12, 2026 | 4.671 |
| August 11, 2026 | 4.607 |
| August 10, 2026 | 4.528 |
| August 07, 2026 | 4.589 |
| August 06, 2026 | 4.557 |
| August 05, 2026 | 4.487 |
| August 04, 2026 | 4.519 |
| August 03, 2026 | 4.365 |
| July 31, 2026 | 4.333 |
| July 30, 2026 | 4.583 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.787 |
| Corcept Therapeutics, Inc. | 18.22 |
| Veru, Inc. | 1.454 |
| Johnson & Johnson | 7.306 |
| Eli Lilly & Co. | 32.40 |
Price to Book Value Related Metrics
| PEG Ratio | -3.195 |
| Price | 24.00 |
| Earnings Yield | -10.31% |
| Market Cap | 842.25M |
| PEGY Ratio | -3.195 |